# A Study To Investigate The Effect Of Inhaling A Single Dose Of GW642444M In Asthmatic Patients

> **NCT00463697** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 20 (actual)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive

## Interventions

- **DRUG:** GW642444H (100mcg)
- **DRUG:** placebo
- **DRUG:** GW642444M (25, 100 & 400 mcg)

## Key facts

- **NCT ID:** NCT00463697
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04-02
- **Primary completion:** 2007-08-04
- **Final completion:** 2007-08-04
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2017-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00463697

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00463697, "A Study To Investigate The Effect Of Inhaling A Single Dose Of GW642444M In Asthmatic Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00463697. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*